(Q37325660)

19 August 2017

1 reference

title

Endothelial progenitor cells: implications for cardiovascular disease (English)

1 reference

19 August 2017

0 references

cardiovascular disease

1 reference

Sven Möbius-Winkler

1

1 reference

19 August 2017

Robert Höllriegel

series ordinal

2

1 reference

19 August 2017

Gerhard Schuler

series ordinal

3

1 reference

19 August 2017

Volker Adams

series ordinal

4

1 reference

19 August 2017

publication date

1 January 2009

1 reference

19 August 2017

1 reference

19 August 2017

volume

75

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

25-37

1 reference

Autologous bone marrow cell implantation as therapeutic angiogenesis for ischemic hindlimb in diabetic rat model

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

Origin of endothelial progenitors in human postnatal bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

The role of basement membrane in angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

Exercise training improves conduit vessel function in patients with coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

Circulating hematopoietic progenitor cells in runners

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

The prevalence of peripheral arterial disease in a defined population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

Intermittent claudication. A risk profile from The Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endothelial progenitor cells: isolation and characterization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endothelial progenitor cells: characterization and role in vascular biology

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Increase of circulating endothelial progenitor cells in patients with coronary artery disease after exercise-induced ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Therapeutical potential of blood-derived progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Immunoelectron microscopic characterization of human dermal lymphatic microvascular endothelial cells. Differential expression of CD31, CD34, and type IV collagen with lymphatic endothelial cells vs blood capillary endothelial cells in normal human

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Biology and plasticity of CD133+ hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

The origin and in vivo significance of murine and human culture-expanded endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Mobilization of endothelial progenitor cells in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Autologous culture-modified mononuclear cells confer vascular protection after arterial injury

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Low-dose aspirin promotes endothelial progenitor cell migration and adhesion and prevents senescence

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Adiponectin promotes endothelial progenitor cell number and function.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Angiogenesis assays: a critical overview

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

The sponge/Matrigel angiogenesis assay.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Prolonged use of high-dose morphine impairs angiogenesis and mobilization of endothelial progenitor cells in mice

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Mobilized Endothelial Progenitor Cells by Granulocyte-Macrophage Colony-Stimulating Factor Accelerate Reendothelialization and Reduce Vascular Inflammation After Intravascular Radiation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1–Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Exercise has a positive effect on endothelial progenitor cells, which could be necessary for vascular adaptation processes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Role of c-kit/Kit ligand signaling in regulating vasculogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovasc

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Effect of exercise on coronary endothelial function in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endothelial progenitor cells for cardiovascular regeneration

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

A maximal exercise bout increases the number of circulating CD34+/KDR+ endothelial progenitor cells in healthy subjects. Relation with lipid profile

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Effects of exercise training on endothelial progenitor cells in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Exercise capacity and circulating endothelial progenitor cells in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Haematopoietic stem cells and endothelial progenitor cells in healthy men: effect of aging and training

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Aging, exercise, and endothelial progenitor cell clonogenic and migratory capacity in men

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Increasing physical education in high school students: effects on concentration of circulating endothelial progenitor cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Circulating progenitor cells decrease immediately after marathon race in advanced-age marathon runners

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Bone marrow cells regenerate infarcted myocardium

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Clinical applications of stem cells for the heart

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Transplanted adult bone marrow cells repair myocardial infarcts in mice

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Transdifferentiation of Human Peripheral Blood CD34 + -Enriched Cell Population Into Cardiomyocytes, Endothelial Cells, and Smooth Muscle Cells In Vivo

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin Rapid Communication

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Autologous mononuclear bone marrow cells during reparative regeneratrion after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI).

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Combined transplantation of skeletal myoblasts and angiopoietic progenitor cells reduces infarct size and apoptosis and improves cardiac function in chronic ischemic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Human mesenchymal stem cells improve myocardial performance in a splenectomized rat model of chronic myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Autologous bone-marrow stem-cell transplantation for myocardial regeneration

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Evidence that intracoronary-injected CD133+ peripheral blood progenitor cells home to the myocardium in chronic postinfarction heart failure.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Transplantation of blood-derived progenitor cells after recanalization of chronic coronary artery occlusion: first randomized and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Management of peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20669

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.20669

1 reference

19 August 2017

1 reference